Cargando…

Radiogenomics correlation between MR imaging features and mRNA-based subtypes in lower-grade glioma

BACKGROUND: To investigate associations between lower-grade glioma (LGG) mRNA-based subtypes (R1-R4) and MR features. METHODS: mRNA-based subtyping was obtained from the LGG dataset in The Cancer Genome Atlas (TCGA). We identified matching patients (n = 145) in The Cancer Imaging Archive (TCIA) who...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zhenyin, Zhang, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322922/ https://www.ncbi.nlm.nih.gov/pubmed/32600353 http://dx.doi.org/10.1186/s12883-020-01838-6

Ejemplares similares

MR Fingerprinting—A Radiogenomic Marker for Diffuse Gliomas
por: Springer, Elisabeth, et al.
Publicado: (2022)

Identification of tumor antigens and immune subtypes in lower grade gliomas for mRNA vaccine development
por: Ye, Liguo, et al.
Publicado: (2021)

Radiogenomics of lower-grade gliomas: a radiomic signature as a biological surrogate for survival prediction
por: Qian, Zenghui, et al.
Publicado: (2018)

Identification of tumor-associated antigens and immune subtypes of lower-grade glioma and glioblastoma for mRNA vaccine development
por: Wang, Zhi-liang, et al.
Publicado: (2022)

Applications of Radiomics and Radiogenomics in High-Grade Gliomas in the Era of Precision Medicine
por: Fathi Kazerooni, Anahita, et al.
Publicado: (2021)

Radiogenomic association of deep MR imaging features with genomic profiles and clinical characteristics in breast cancer
por: Liu, Qian, et al.
Publicado: (2023)

Molecular Subtypes of Glioblastoma Are Relevant to Lower Grade Glioma
por: Guan, Xiaowei, et al.
Publicado: (2014)

Radiomics and radiogenomics in gliomas: a contemporary update
por: Singh, Gagandeep, et al.
Publicado: (2021)

Microvascular characteristics of lower-grade diffuse gliomas: investigating vessel size imaging for differentiating grades and subtypes
por: Guo, Hong, et al.
Publicado: (2018)

Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma
por: Zhao, Jingwei, et al.
Publicado: (2020)

Radiomics and Qualitative Features From Multiparametric MRI Predict Molecular Subtypes in Patients With Lower-Grade Glioma
por: Sun, Chen, et al.
Publicado: (2022)

Identification of molecular subtypes based on inflammatory response in lower-grade glioma
por: Lin, Wanzun, et al.
Publicado: (2022)

Prediction of Molecular Mutations in Diffuse Low-Grade Gliomas using MR Imaging Features
por: Shboul, Zeina A., et al.
Publicado: (2020)

MRI-Based Radiomics and Radiogenomics in the Management of Low-Grade Gliomas: Evaluating the Evidence for a Paradigm Shift
por: Habib, Ahmed, et al.
Publicado: (2021)

Utility of FET-PET in detecting high-grade gliomas presenting with equivocal MR imaging features
por: Puranik, Ameya D., et al.
Publicado: (2019)

Protocol for integrative subtyping of lower-grade gliomas using the SUMO pipeline
por: Sienkiewicz, Karolina, et al.
Publicado: (2022)

Quantitative magnetic resonance imaging and radiogenomic biomarkers for glioma characterisation: a systematic review
por: Seow, Pohchoo, et al.
Publicado: (2018)

Preoperative Diagnosis and Molecular Characterization of Gliomas With Liquid Biopsy and Radiogenomics
por: Balana, Carmen, et al.
Publicado: (2022)

Perfusion MR Imaging in Gliomas: Comparison with Histologic Tumor Grade
por: Lee, Sun Joo, et al.
Publicado: (2001)

Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine
por: Zhong, Hua, et al.
Publicado: (2021)

Identification of tumor antigens and immune subtypes of glioma for mRNA vaccine development
por: Chen, Zhuohui, et al.
Publicado: (2022)

Breast Ultrasound Microvascular Imaging and Radiogenomics
por: Park, Ah Young, et al.
Publicado: (2021)

Lower Grade Gliomas
por: Youssef, Gilbert, et al.
Publicado: (2020)

Longitudinal MR spectroscopy to detect progression in patients with lower-grade glioma in the surveillance phase
por: Avalos, Lauro N, et al.
Publicado: (2022)

Magnetic Resonance Spectroscopy, Positron Emission Tomography and Radiogenomics—Relevance to Glioma
por: Chiang, Gloria C., et al.
Publicado: (2018)

Radiogenomic analysis of vascular endothelial growth factor in patients with diffuse gliomas
por: Sun, Zhiyan, et al.
Publicado: (2019)

Fused feature signatures to probe tumour radiogenomics relationships
por: Xia, Tian, et al.
Publicado: (2022)

Radiogenomics study to predict the nuclear grade of renal clear cell carcinoma()
por: He, Xuan-ming, et al.
Publicado: (2023)

Recognition of Tumor-Associated Antigens and Immune Subtypes in Glioma for mRNA Vaccine Development
por: Ma, Shuai, et al.
Publicado: (2021)

Combining molecular and imaging metrics in cancer: radiogenomics
por: Lo Gullo, Roberto, et al.
Publicado: (2020)

Rab27a Was Identified as a Prognostic Biomaker by mRNA Profiling, Correlated with Malignant Progression and Subtype Preference in Gliomas
por: Wang, Hongjun, et al.
Publicado: (2014)

Radiomics Features Predict CIC Mutation Status in Lower Grade Glioma
por: Zhang, Luyuan, et al.
Publicado: (2020)

Molecular profiles of tumor contrast enhancement: A radiogenomic analysis in anaplastic gliomas
por: Liu, Xing, et al.
Publicado: (2018)

Assessing Versatile Machine Learning Models for Glioma Radiogenomic Studies across Hospitals
por: Kawaguchi, Risa K., et al.
Publicado: (2021)

Identification of three tumor antigens and immune subtypes for mRNA vaccine development in diffuse glioma
por: Zhou, Quanwei, et al.
Publicado: (2021)

Radiogenomics of lung cancer
por: Wong, Chi Wah, et al.
Publicado: (2020)

Radiogenomics in Colorectal Cancer
por: Badic, Bogdan, et al.
Publicado: (2021)

Hypoxia-Related lncRNA Correlates With Prognosis and Immune Microenvironment in Lower-Grade Glioma
por: Xu, Shengchao, et al.
Publicado: (2021)

YTHDF2 correlates with tumor immune infiltrates in lower-grade glioma
por: Lin, Xiangan, et al.
Publicado: (2020)

Clinico-neuropathological features of isocitrate dehydrogenase 2 gene mutations in lower-grade gliomas
por: Wang, Lei-Ming, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3qk2p41uj7mesqjfgoccslcq1v